Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
0.99
0.02 (1.65%)
At close: Jun 17, 2025, 10:53 AM
1.65% (1D)
| Bid | 0.98 |
| Market Cap | 55.7M |
| Revenue (ttm) | 7M |
| Net Income (ttm) | -127.83M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -0.59 |
| Forward PE | -0.83 |
| Analyst | Buy |
| Ask | 1.03 |
| Volume | 28,333 |
| Avg. Volume (20D) | 179,430 |
| Open | 0.98 |
| Previous Close | 0.97 |
| Day's Range | 0.96 - 1.02 |
| 52-Week Range | 0.61 - 6.80 |
| Beta | 1.24 |
About PRLD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRLD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRLD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
6 days ago · https://www.defenseworld.net
Two Sigma Investments LP Purchases 174,906 Shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD)Two Sigma Investments LP grew its position in Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) by 307.2% in the fourth quarter, according to its most recent 13F filing with the Secu...
